Abstract

Natural killer (NK) cells play a pivotal role in cancer immunotherapy due to their innate ability to detect and kill tumorigenic cells. The decision to kill is determined by the expression of a myriad of activating and inhibitory receptors on the NK cell surface. Cell-to-cell engagement results in either self-tolerance or a cytotoxic response, governed by a fine balance between the signaling cascades downstream of the activating and inhibitory receptors. To evade a cytotoxic immune response, tumor cells can modulate the surface expression of receptor ligands and additionally, alter the conditions in the tumor microenvironment (TME), tilting the scales toward a suppressed cytotoxic NK response. To fully harness the killing power of NK cells for clinical benefit, we need to understand what defines the threshold for activation and what is required to break tolerance. This review will focus on the intracellular signaling pathways activated or suppressed in NK cells and the roles signaling intermediates play during an NK cytotoxic response.

Highlights

  • Natural Killer (NK) cells are bone marrow–derived innate lymphocytes that are found in most organs, with the largest population of NK cells residing in the blood [1]

  • Following CD16, NKG2D and NCR family receptor engagement adaptor proteins, DNAX-activating Protein 12 (DAP12), CD3ζ and FCRγ are rapidly phosphorylated within their immunoreceptor tyrosine-based activation motifs (ITAMs) sequences by an as yet unidentified Src-kinase, which leads to adaptor association with Spleen tyrosine kinase (Syk) or Zap70 tyrosine kinases (Figure 3B) [215,271,272]

  • The inhibitory signals appear to act by blocking early activation, for example, NKG2D, DNAX accessory molecule-1 (DNAM-1), 2B4, NTB-A and CD2-like receptor-activating cytotoxic cell (CRACC) all converge at Vav-1 dephosphorylation (Figure 3A), which would prevent microtubule-organizing center (MTOC) formation and result in tolerance

Read more

Summary

Introduction

Natural Killer (NK) cells are bone marrow–derived innate lymphocytes that are found in most organs, with the largest population of NK cells residing in the blood [1]. Cancers 2020, 12, 952 engagement and cell killing, with receptor-ligand interactions thought to be the initiating step in the formation of an immunological synapse (IS) (Figure 1A,B) [20,21]. This is followed by recruitment of filamentous actin (F-actin) to the IS (Figure 1B) and polarization of the lytic granules and the microtubule-organizing center (MTOC) toward the class.

Immunological synapse
Receptor Mediated Inhibition of NK Cells
Non-MHC-I Recognizing Receptors
Current Therapies Harnessing the Power of Inhibitory NK Receptors
Inhibitory NK Signaling
SHP1 and SHP-2 Signaling
TAM Signaling
Activating NK Cell Receptors
Current Therapies Harnessing the Power of Activating NK Receptors
ITAM Signaling
Releasing the Brake
Findings
Conclusion and Future Directions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.